Clinical Edge Journal Scan

Clinical Edge Journal Scan

Differential impact of multiple sclerosis therapies on SARS-CoV-2 vaccine-induced immune response

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Multiple sclerosis: Evidence spanning 3 decades finds no influence of DMTs on neoplasm incidence

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Multiple sclerosis relapses are prevalent after natalizumab cessation during pregnancy

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Third COVID-19 vaccine dose shows benefit in MS patients with a weak response after 2 doses

Publish date: February 22, 2022

Read More

Clinical Edge Journal Scan

Clinical Edge Journal Scan Commentary: Multiple Sclerosis February 2022

Author:: Mark Gudesblatt, MD

Publish date: February 1, 2022

Read More

Clinical Edge Journal Scan

Presence of multiple sclerosis may increase risk for myocardial infarction but not stroke

Publish date: January 19, 2022

Read More

Clinical Edge Journal Scan

Trigeminal neuralgia is more common in women vs men with MS

Publish date: January 19, 2022

Read More

Clinical Edge Journal Scan

Ocrelizumab outperforms fingolimod after natalizumab cessation in RRMS

Publish date: January 19, 2022

Read More

Clinical Edge Journal Scan

Cognitive dysfunction predicts poor prognosis and mortality in multiple sclerosis

Publish date: January 19, 2022

Read More

Clinical Edge Journal Scan

Increased sun and UVR exposure protective against developing pediatric MS

Publish date: January 19, 2022

Read More

Pages

FULL MENU FULL MENU
More
- MDedge Neurology